SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-028396
Filing Date
2023-08-14
Accepted
2023-08-14 16:05:37
Documents
68
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1434992
2 ex31-1.htm EX-31.1 18716
3 ex31-2.htm EX-31.2 18459
4 ex32-1.htm EX-32.1 8245
5 ex32-2.htm EX-32.2 8192
  Complete submission text file 0001493152-23-028396.txt   6965622

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ocea-20230630.xsd EX-101.SCH 62203
7 XBRL CALCULATION FILE ocea-20230630_cal.xml EX-101.CAL 47037
8 XBRL DEFINITION FILE ocea-20230630_def.xml EX-101.DEF 262532
9 XBRL LABEL FILE ocea-20230630_lab.xml EX-101.LAB 392985
10 XBRL PRESENTATION FILE ocea-20230630_pre.xml EX-101.PRE 320133
62 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1216930
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40793 | Film No.: 231169822
SIC: 2834 Pharmaceutical Preparations